Nomadic,
They note risk given the size of the acquisition (and ongoing auditor opinion), but also potential for the acquisition to be highly accretive for EPS.
The acquisition is 1/4 of its market cap, but clearly the potential is there. Sales growth and potential integration saving costs not factored in. I'm sure UBS didn't increase their shareholding for nothing. They benefit from buying more shares and now can take up all their entitlements at $10.
- Forums
- Charts
- Web Chart
WEB
web travel group limited
Add to My Watchlist
3.12%
!
$4.35

Nomadic, They note risk given the size of the acquisition (and...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.35 |
Change
-0.140(3.12%) |
Mkt cap ! $1.571B |
Open | High | Low | Value | Volume |
$4.49 | $4.52 | $4.27 | $30.42M | 7.018M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | $4.34 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.37 | 500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 4.340 |
1 | 3001 | 4.290 |
2 | 1882 | 4.270 |
3 | 10312 | 4.260 |
10 | 34515 | 4.250 |
Price($) | Vol. | No. |
---|---|---|
4.430 | 800 | 1 |
4.480 | 8800 | 2 |
4.500 | 4000 | 2 |
4.520 | 6000 | 2 |
4.570 | 8000 | 2 |
Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
Featured News
WEB (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online